EUVIMEDObjevte EUVIMED
Beobachtungsstudie

Primary Prevention of Clostridioides difficile Infection With Oral Vancomycin in Pediatric Hematopoietic Stem Cell Transplant Patients

Heather Valdin iD, Blake Gray, Gregory Cook, Mackenzie Creamer, Lolie Yu, Zachary LeBlanc

Pediatric Transplantation · 2025

DOI: 10.1111/petr.70246 ↗

At a glance

Beobachtungsstudie in Pediatric Transplantation, 2025. Written by Heather Valdin and 5 co-authors. Institution: Department of Pediatric Hematology Oncology, Louisiana State University Health Sciences Center and Manning Family Children's, New Orleans, Louisiana,…. Major MEDLINE topics: Hematopoietic Stem Cell Transplantation, Vancomycin, Clostridium Infections, Anti-Bacterial Agents. 9 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Clostridioides difficile infection (CDI) poses a significant risk to pediatric hematopoietic stem cell transplant (HSCT) due to microbiome disruption, mucosal injury, and graft versus host disease (GVHD). While oral vancomycin prophylaxis (OVP) is effective for preventing recurrent CDI, evidence for its role in preventing initial infection is limited. Our institution employs empiric OVP during the first HSCT admission to prevent initial CDI.

Objectives

We sought to describe the incidence of CDI among pediatric HSCT recipients receiving OVP and to evaluate secondary outcomes related to OVP exposure.

Methods

We conducted a single center, retrospective observational study of 84 pediatric HSCT recipients at our institution receiving OVP during their initial transplant admission. Chart review captured demographics, transplant information, and clinical outcomes. The primary outcome was CDI incidence during hospitalization. Secondary outcomes included VRE infections, refractory CDI following cessation of OVP, and acute GI GVHD.

Results

Only one patient developed CDI (1.19%) while on OVP, despite universal exposure to high‐risk antibiotics among the entire cohort. No VRE infections were observed. Rates of GI aGVHD were consistent with national averages. Nine patients (10.7%) developed CDI after discontinuing OVP, all managed with standard treatment.

Conclusion

Empiric OVP during pediatric HSCT hospitalization was associated with a markedly low CDI incidence. Despite theoretical risks of microbiome disruption, no adverse effects were identified in this cohort, including long‐term follow‐up beyond 5 years. These findings support the safety and potential efficacy of OVP as primary CDI prophylaxis in pediatric HSCT patients.

Subjects

MeSH terms (MEDLINE)

Hematopoietic Stem Cell TransplantationVancomycinClostridium InfectionsAnti-Bacterial AgentsAntibiotic ProphylaxisPrimary PreventionPostoperative ComplicationsHumansRetrospective StudiesFemaleMaleChildChild, PreschoolAdolescentAdministration, OralIncidenceInfantClostridioides difficile

Author keywords

Clostridioides difficile infection preventionoral vancomycin prophylaxispediatric bone marrow transplant

Substances

VancomycinAnti-Bacterial Agents

Authors and institutions

  • Department of Pediatric Hematology Oncology, Louisiana State University Health Sciences Center and Manning Family Children's, New Orleans, Louisiana, USA.
  • Louisiana State University Health Sciences Center School of Medicine, New Orleans, Louisiana, USA.
  • Department of Pharmacy, Manning Family Children's, New Orleans, Louisiana, USA.

ORCID profiles: Heather Valdin

Cite

APA

Valdin, H., Gray, B., Cook, G., Creamer, M., Yu, L., & LeBlanc, Z. (2025). Primary Prevention of Clostridioides difficile Infection With Oral Vancomycin in Pediatric Hematopoietic Stem Cell Transplant Patients. Pediatric Transplantation. https://doi.org/10.1111/petr.70246

Vancouver

Valdin H, Gray B, Cook G, Creamer M, Yu L, LeBlanc Z. Primary Prevention of Clostridioides difficile Infection With Oral Vancomycin in Pediatric Hematopoietic Stem Cell Transplant Patients. Pediatric Transplantation. 2025. doi:10.1111/petr.70246

BibTeX
@article{Valdin2025,
  author = {Valdin, Heather and Gray, Blake and Cook, Gregory and Creamer, Mackenzie and Yu, Lolie and LeBlanc, Zachary},
  title = {Primary Prevention of Clostridioides difficile Infection With Oral Vancomycin in Pediatric Hematopoietic Stem Cell Transplant Patients},
  journal = {Pediatric Transplantation},
  year = {2025},
  doi = {10.1111/petr.70246}
}
Start for free →